Longitudinal Costs of Image-Guided Intensity-Modulated Radiation Therapy Versus Three-Dimensional Conformal Radiation: Lessons From Phase III PARCER Trial for Shaping Resource-Stratified Guidelines in Low- and Middle-Income Countries.
Varsha HandeNilesh RanjanSupriya ChopraShwetabh SinhaPrachi MittalAnkita GuptaAmita MaheshwariSudeep GuptaPublished in: JCO global oncology (2024)
Although the initial costs of IG-IMRT are high, on the basis of longitudinal data, it is financially inefficient to treat with 3D-CRT. Resource-stratified guidelines should include longitudinal health intervention costs rather than solely initial costs for policy decisions to implement advanced radiation technology.
Keyphrases
- phase iii
- radiation therapy
- clinical trial
- public health
- open label
- healthcare
- cross sectional
- phase ii
- randomized controlled trial
- mental health
- radiation induced
- clinical practice
- electronic health record
- health information
- heart failure
- big data
- machine learning
- placebo controlled
- climate change
- artificial intelligence
- risk assessment
- atrial fibrillation
- locally advanced